Primary Site >> Liver Cancer
Gene >> TLR9
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. PMID: 18064579 Ref: Toll-like receptor 7 and 9 expression in peripheral blood mononuclear cells from patients with chronic hepatitis B and related hepatocellular carcinoma. PMID: 18215354 |
Ref: Production of antibodies with peptide-CpG-DNA-liposome complex without carriers. PMID: 21592346 Ref: Hepatitis B virus impairs TLR9 expression and function in plasmacytoid dendritic cells. PMID: 22046272 |
Ref: Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population. PMID: 21932384 Ref: Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. PMID: 22297845 Ref: The association between Toll-like receptor 2 single-nucleotide polymorphisms and hepatocellular carcinoma susceptibility. PMID: 22309608 |
Ref: The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma. PMID: 23467704 Ref: Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. PMID: 23855294 |
Ref: Toll-like receptors 3, 4 and 9 in hepatocellular carcinoma: Relationship with clinicopathological characteristics and prognosis. PMID: 23742263 Ref: Phosphorothioate-modified CpG oligodeoxynucleotide (CpG ODN) induces apoptosis of human hepatocellular carcinoma cells independent of TLR9. PMID: 24452201 Ref: Phosphorothioate modification of the TLR9 ligand CpG ODN inhibits poly(I:C)-induced apoptosis of hepatocellular carcinoma by entry blockade. PMID: 25224571 Ref: Hepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions. PMID: 26676160 |
Ref: Effect of toll-like receptor 7 and 9 targeted therapy to prevent the development of hepatocellular carcinoma. PMID: 24990399 Ref: Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9. PMID: 25681553 |
Ref: Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation. PMID: 25524262 Ref: Innate immunity and hepatocarcinoma: Can toll-like receptors open the door to oncogenesis? PMID: 26839640 Ref: Therapeutic Injection of a C-Type CpG ODN Induced an Antitumor Immune Response in C57/BL6 Mice of Orthotopically Transplanted Hepatocellular Carcinoma. PMID: 27131318 Ref: Expression of toll-like receptors in hepatic cirrhosis and hepatocellular carcinoma. PMID: 27420991 Ref: Therapeutic Injection of a C-Type CpG ODN Induced an Antitumor Immune Response in C57/BL6 Mice of Orthotopically Transplanted Hepatocellular Carcinoma. PMID: 27931288 |
Ref: Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interaction. PMID: 28370295 Ref: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD. PMID: 28939830 Ref: [Expression of Toll-like receptors in human hepatocellular carcinoma and its correlation with inflammasome-associated cytokines]. PMID: 29089073 |
Ref: The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice. PMID: 28875549 Ref: Enhanced B-cell differentiation driven by advanced cirrhosis resulting in hyperglobulinemia. PMID: 29427373 Ref: Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV. PMID: 30321082 |